About Emerald Health Therapeutics

Based in British Columbia and federally licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR), we cultivate medical cannabis using proven and standardized growing methods while applying our research capabilities to discover potential medicinal benefits of cannabis for the future.


Our dedicated team includes talented MDs, PhDs, engineers and horticulturists with extensive experience, collectively offering more than 60 years of cannabis growing leadership, knowledge and commitment.


The combination of committed scientists and strains gives us the privileged ability to develop new varieties through plant genetics. Our access to widely recognized experts in development of botanical, nutraceutical and pharmaceutical medicines and the ability to carry out clinical trials is helping lead the way for the future of medicinal cannabis.


A federal research grant recipient, we have devoted substantial additional resources toward research and development, funding projects relating to the characterization of cannabis strains and cultivation technologies.  Additionally, we collaborate with academic and medical researchers, to further the understanding of the effect of cannabis and cannabinoids on human health.  We are a proud sponsor of the Arthritis Society.

Management Team

Chris Wagner

Chief Executive Officer

Bin Huang, PhD, MBA


Robert C. Hill, CPA

Chief Financial Officer

Frey Garabagi, PhD

VP, Research and Quality Affairs

Traviss Graham

VP, Production

Michael Bierman

VP Operations

Investors Info

Emerald Health Therapeutics [Canada] Inc. is a TSX Venture Exchange listed company (TSXV:EMH), and is a licensed producer of medical cannabis in Canada.

For more information on Emerald Health Therapeutics please visit emeraldhealth.ca
or email us at


Our extensive FAQs should help answer your questions. GO TO FAQs